Vanguard Group’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49M | Sell |
4,762,903
-562,134
| -11% | -$412K | ﹤0.01% | 3330 |
|
|
2025
Q1 | $5.33M | Buy |
5,325,037
+752,729
| +16% | +$753K | ﹤0.01% | 3145 |
|
|
2024
Q4 | $48.5M | Buy |
4,572,308
+195,142
| +4% | +$2.07M | ﹤0.01% | 2170 |
|
|
2024
Q3 | $57.8M | Buy |
4,377,166
+1,103,042
| +34% | +$14.6M | ﹤0.01% | 2118 |
|
|
2024
Q2 | $32.2M | Buy |
3,274,124
+2,939,794
| +879% | +$28.9M | ﹤0.01% | 2333 |
|
|
2024
Q1 | $4.6M | Sell |
334,330
-46,624
| -12% | -$641K | ﹤0.01% | 3334 |
|
|
2023
Q4 | $6.5M | Buy |
380,954
+330,954
| +662% | +$5.64M | ﹤0.01% | 3181 |
|
|
2023
Q3 | $706K | Buy |
+50,000
| New | +$706K | ﹤0.01% | 3951 |
|